Similarly, Onyszkiewicz et al. demonstrated that butyrate can enter the bloodstream through the intestinal vascular barrier and act on GPR41 and GPR43 to relax the mesenteric arteries, thereby significantly reducing hypertension [56]. Here, FFAR3 is linked to hypertensive disorder.